We speculate that the proportion of CD4+ iTregs decides whether CD4+ Tregs are antigen-specific and such conflicting results may derive from the fact that there is a larger proportion of natural occurring Tregs (nTregs) in CD4+ Tregs populations during GVHD, which present less targeted immunoregulation. The gene discussed is CD4; the disease is graft versus host disease.